News for October 2016

This year, the Faculty of Dental Surgery of the Royal College of Surgeons has formed partnerships with the British Orthodontic Society (BOS), the British Society of Paediatric Dentistry (BSPD), the British Association for the Study of Community Dentistry (BASCD) and the British Society of Periodontology (BSP) and will be offering a number of research fellowships and small grants under the theme of 'Promoting Children's Oral Health':

  • A Joint FDS RCSEng-BOS for up to two fellowships which will normally be awarded for up to 3 years and is intended to support a clinical trainee in orthodontics to undertake a PhD.
  • Joint FDS RCSEng-BSPD  small grants for up to £10,000 and are intended to support research into the oral health of children in the broadest sense.
  • Joint FDS RCSEng-BASCD small grants for up to £10,000 and are intended to support research designed to benefit community or population oral health.
  • Joint FDS RCSEng-BSP small grants for up to £10,000 and are intended to support research into periodontal disease in the broadest sense. 

In addition to this, the Faculty will continue to invite applications for the FDS Research Fellowships, the FDS Small Grants and the Special 2017 FDS RCSEng 70th Anniversary Research Fellowship:

  • 2017 is the 70th anniversary year of the Faculty of Dental Surgery. The theme of our anniversary celebrations will be innovations and the future of dentistry. This one-year fellowship will therefore be awarded for a research project that will support the development, implementation or evaluation of new innovations or emerging technologies applied to any aspect of dentistry.
  • Research fellowships of up to two years duration to support clinical trainees to obtain research training. The proposed research should be of relevance to oral and dental research.
  • Up to five small research grants up to the value of £10,000 each per year. These small grants are designed to meet research consumables costs for new or existing projects.

Applications are now open and will close on 27 January 2017 at 5pm.

If you have any queries please contact Nikki Walcott: nwalcott@rcseng.ac.uk

Further details at: https://www.rcseng.ac.uk/dental-faculties/fds/research/

BSODR Management Committee changes - 2016

The following changes have been made to the BSODR Management Committee: 

  • Professor David Moles (Plymouth) and Professor Rob Allaker (London) completed their three-year terms of office as Councillor and, following elections in August / September 2016, were replaced by Professor David Wood (Leeds) and Dr Chris Hope (Liverpool). 
  • Dr Chris Nile (Glasgow) stepped down as Councillor (Early Career Researcher) and Dr Katrin Jaedicke (Newcastle) was elected to the post.
  • Professor Peter Robinson (Bristol), who is currently Editor for BSODR, was elected to the post of President Elect and will take up the post of President at the BSODR annual meeting in Plymouth in September 2017.

Congratulations to all members elected to the BSODR Management Committee. BSODR looks forward to working closely with them in the future. BSODR would like to thank to those members who have now stepped down from the committee for all their hard work for the society over the years.

Thanks are also due to all the other candidates who recently stood for election and to our members who voted in the elections.

 

17 October 2016

Consultation on changes to the Technology Appraisals and Highly Specialised Technologies programmes

Please see below information sent by NICE, which may be of interest to some BSODR members:

 

Dear­­ Technology Appraisal and Highly Specialised Technologies stakeholders

Consultation on changes to the Technology Appraisals and Highly Specialised Technologies programmes

Yesterday, NICE and NHS England launched a joint 12 week consultation on changes to the arrangements for evaluating and funding drugs and other health technologies appraised through NICE’s Technology Appraisal (TA) and Highly Specialised Technologies (HST) programmes.

As your organisation is a stakeholder in NICE’s TA and/or HST programme, I am writing to inform you of the details of this new consultation and to invite you to take part.

NICE and NHS England intend to work together more closely to better manage access to new drugs and medical technologies (devices and diagnostics) by simplifying and speeding up some appraisals, and by making the arrangements for funding others more clear. The proposed changes will benefit patients by providing access to the most effective and cost-effective new treatments more quickly and will help the life sciences industry by increasing the opportunities for companies to help manage the introduction of their new technologies into the NHS.

The NHS is committed to providing timely access to new treatments, but introducing new technologies in a way that is both good for UK business and, at the same time, optimises the financial sustainability of the NHS can be challenging. This consultation sets out a number of ways in which NICE and NHS England can provide an environment that encourages the life sciences industry and the NHS to work together in the best interests of patients. By facilitating collaboration and providing opportunities for early dialogue between innovators and the NHS, and by speeding up appraisal and adoption processes, NICE and NHS England can enable the development of arrangements that deliver the right outcomes for both patients and the life sciences industry.

Summary of proposals

·           Introduce a ‘fast track’ NICE technology appraisal process for the most promising new technologies, which fall below an incremental cost-effectiveness ratio of £10,000 per QALY (quality adjusted life year), to get these treatments to patients more quickly.

 

·           Operate a ‘budget impact threshold’ of £20 million, set by NHS England, to signal the need for a dialogue with companies to agree special arrangements to better manage the introduction of new technologies recommended by NICE. This would apply to a small number of technologies that, once determined as cost effective by NICE, would have a significant impact on the NHS budget.

 

·           Vary the timescale for the funding requirement when the budget impact threshold is reached or exceeded, and there is therefore a compelling case that the introduction of the new technology would risk disruption to the funding of other services.

 

·           Automatically fund, from routine commissioning budgets, treatments for very rare conditions (highly specialised technologies) up to £100,000 per QALY (5 times greater than the lower end of NICE’s standard threshold range), and provide the opportunity for treatments above this range to be considered through NHS England’s process for prioritising other highly specialised technologies.

 

The consultation is available via the NICE website: https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-technology-appraisal-guidance/consultation-on-changes-to-technology-appraisals-and-highly-specialised-technologies and will run from Thursday 13 October 2016 until Friday 13 January 2017.

 

We would like to receive comments on the proposals from anyone who has an interest in the TA and HST programmes. Comments can be made via the pro-forma that is available on the consultation webpage.

 

We will also be providing stakeholders with the opportunity to discuss the proposals during the consultation period at the following events:

 

Webinars:

·         1 - 2.30pm on 3 November 2016 (register for this webinar)

·         1 - 2.30pm on 17 November 2016 (register for this webinar)

·           1 - 2.30pm on 20 December 2016 (register for this webinar)

·         1 - 2.30pm on 12 January 2017 (register for this webinar)

Face-to-face events:

·         2 - 4.30pm on 29 November 2016 – central London TBC

·         2 - 4.30pm on 13 December 2016 – central Manchester TBC

 

To register to attend the face-to-face events, please complete the nomination form and email to TAandHSTconsultation2016@nice.org.uk.

 

17 October 2016

May 17-20, 2017 | Hotel Zuiderduin, Egmond aan Zee, the Netherlands

It is with pleasure that we announce the 11th European Symposium on Saliva. The symposium will deal with all different aspects of saliva and salivary glands in dentistry and medicine, the application of saliva as a diagnostic fluid and the effect of saliva on food and taste experience. We want to bring together scientists from all fields of salivary research and promote scientific exchange. Therefore, you are invited to submit an abstract and present your work by an oral or poster presentation. Key note lectures of invited speakers, all experts in their field, are alternated with short presentations of participants. We look forward to welcome you in Egmond aan Zee.

On behalf of the organizing committee,
Toon Ligtenberg (a.ligtenberg@acta.nl)

4 October 2016   Symposium website